About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AMED - Amedisys Inc| Previous Close | $255.15 | Open | $258.10 |
| Volume | 160.4K | Market Cap | 8.332B |
| Yield | Last Dividend |
| Oppenheimer Stick to Their Buy Rating fo... | 02/25/21 |
| Oppenheimer Stick to Their Buy Rating for Amedisys Inc | |
| Amedisys: Q4 Earnings Insights | 02/24/21 |
| Shares of Amedisys (NASDAQ:AMED) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share ??? | |
| Amedisys Earnings and Growth Analysis : ... | 02/23/21 |
| Amedisys announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Will Higher Business Volumes Aid Teladoc... | 02/22/21 |
| Stocks Analysis by Zacks Investment Research covering: Medtronic PLC, Amedisys Inc, Lexicon Pharmaceuticals Inc, Teladoc Inc. Read Zacks Investment Re... | |
| Home Healthcare Monitoring Device Market... | 02/18/21 |
| Stratagem Market Insights has announced the addition of the "Home Healthcare Monitoring Device Market Report 2020-2027 Production, Sales And Consumpti... | |
| Insider Selling: Amedisys, Inc. (NASDAQ:... | 01/30/21 |
| Amedisys, Inc. (NASDAQ:AMED) insider Denise M. Bohnert sold 454 shares of the business???s stock in a transaction dated Monday, January 25th. The shar... | |
| Skilled Nursing Care Services Market Gro... | 01/25/21 |
| Global Skilled Nursing Care Services Market Analysis to 2024 is a specialized and in-depth study of the Skilled Nursing Care Services industry with a ... | |
| Home Healthcare Market 2021: Magnificien... | 01/25/21 |
| A new market study is released on Global "Home Healthcare Market 2021" with data Tables for historical and forecast years represented with Chats & Gra... | |
| Barclays Stick to Their Buy Rating for A... | 01/17/21 |
| Barclays Stick to Their Buy Rating for Amedisys Inc | |
| RBC Capital Stick to Their Buy Rating fo... | 01/05/21 |
| RBC Capital Stick to Their Buy Rating for Amedisys Inc | |
| Leading Healthcare Services Organization... | 01/05/21 |
| BATON ROUGE, La. and BANNOCKBURN, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice an... | |
| FXNEWS24 |Amedisys (AMED) Moves to Buy: ... | 12/30/20 |
| Amedisys (AMED) Moves to Buy: Rationale Behind the Upgrade | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News | |
| Home Healthcare Market Latest Innovation... | 12/03/20 |
| Databridgemarketresearch.com Present ???Home Healthcare Market??? Industry Trends and Forecast to 2027??? new report to its research database. The rep... | |
| Home Healthcare Market worth USD 274.7 b... | 11/24/20 |
| According to the new market research report "Home Healthcare Market by Product (Dialysis Equipment, Ventilators, ECG, Canes, Wheelchairs, Activity Mon... | |
| Amedisys to Present at the Jefferies Vir... | 11/16/20 |
| BATON ROUGE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care??? | |
| Home Healthcare Market 2020 High Demand ... | 11/05/20 |
| Databridgemarketresearch.com announces the release of the report "Home Healthcare Market" Size, Share & Trends Analysis Report By 2027. The market dat... | |
| FXNEWS24 |Despite A Q3 Beat The Rally In... | 10/30/20 |
| Despite A Q3 Beat The Rally In Amedisys Stock Appears Overdone | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News | |
| Amedisys Reports Third Quarter 2020 Fina... | 10/28/20 |
| BATON ROUGE, La., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month??? | |
| Home Healthcare Market 2020 Analysis by ... | 10/26/20 |
| Global Home Healthcare Market report brings together a meticulous study of the present and upcoming opportunities to elucidate the future investment i... | |
| Global Home Healthcare Market 2020-2026 ... | 10/22/20 |
| Data Bridge Market Research has recently added a concise research on the Home Healthcare Market - Industry Trends and Forecast to 2026. A reliable Hom... | |
| Christopher Gerard Sells 1,500 Shares of... | 10/21/20 |
| Amedisys Inc (NASDAQ:AMED) COO Christopher Gerard sold 1,500 shares of the company???s stock in a transaction on Thursday, October 15th. The shares we... | |
| Amedisys (AMED) Set to Announce Earnings... | 10/20/20 |
| Amedisys (NASDAQ:AMED) will be posting its quarterly earnings results after the market closes on Wednesday, October 28th. Analysts expect Amedisys to ... | |
| Amedisys Inc (NASDAQ:AMED) COO Christoph... | 10/19/20 |
| Amedisys Inc (NASDAQ:AMED) COO Christopher Gerard sold 1,500 shares of the stock in a transaction that occurred on Thursday, October 15th. The shares ... | |
| COVID-19 Impact On Global Home Healthcar... | 10/14/20 |
| Data Bridge Market Research has recently added a concise research on the Global Home Healthcare Market to depict valuable insights related to signific... | |
| COVID-19 UPDATE: Global Home Healthcare ... | 10/07/20 |
| Home Healthcare Market research report has been prepared with a nice combination of industry insight, smart solutions, practical solutions and newest ... | |
| Home Healthcare Market 2020 Incredible P... | 10/07/20 |
| To prepare this Home Healthcare Market research report, an array of objectives of market research has been considered. While formulating this market r... | |
| RBC lays out 6 trades to make now ahead ... | 07/31/20 |
| Lori Calvasina, RBC's head of US equity strategy, says her firm's analysts believe a victory for Biden and the Democrats would be "bearish or very bea... | |
| Amedisys EPS beats by $0.53, beats on re... | 07/28/20 |
| Amedisys (NASDAQ:AMED): Q2 Non-GAAP EPS of $1.34 beats by $0.53; GAAP EPS of $1.04 beats by $0.15. Revenue of $485.06M (-1.6% Y/Y) beats by $16.68M. P... | |
| Amedisys Reports Second Quarter 2020 Fin... | 07/28/20 |
| BATON ROUGE, La., July 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month per... | |
| Should You Avoid Amedisys Inc (AMED)? | 06/19/20 |
| In this article you are going to find out whether hedge funds think Amedisys Inc (NASDAQ:AMED) is a good investment right now. We like to check what t... | |
| Buy rating | 02/23/21 |
| Benchmark maintains Buy rating and raises Price Target from $275.00 to $325.00 | |
| Buy rating | 02/08/21 |
| Deutsche Bank maintains Buy rating and raises Price Target from $275.00 to $340.00 | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | $1.47/ 553.37M |
| Actual (EPS/Rev.) | $1.49/ $550.71 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
